Non-alcoholic fatty liver disease (NAFLD) is one of the types of fatty liver which occurs when fat is deposited (steatosis) in the liver due to causes other than excessive alcohol use. Non-alcoholic steatohepatitis (NASH) is the most extreme form of NAFLD. NAFLD is the most common liver disorder in developed countries .
Overview of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) including causes, symptoms, diagnosis, and treatment.
Learn about the health conditions that make you more likely to develop NAFLD and NASH. NAFLD and NASH are usually silent diseases with few or no symptoms.
What is nonalcoholic steatohepatitis (NASH)? Nonalcoholic steatohepatitis ( NASH) is liver inflammation caused by a buildup of fat in the liver. NASH is part of a group of liver diseases, known as nonalcoholic fatty liver disease, in which fat builds up in the liver and sometimes causes liver damage that gets worse over time ...
NASH is a rapidly growing and dangerous liver disease that can be diagnosed in individuals ranging from 4 to 80 years of age, and currently has no treatment options.
Learn about the causes, symptoms, diagnosis & treatment of Approach to the Patient With Liver Disease from the Professional Version of the Merck Manuals.
Jul 6, 2017 ... Millions of people are living with a "silent" disease they've likely never heard of. NASH, short for nonalcoholic steatohepatitis, is a type of liver disease in which liver fat builds up in people. NASH has become more common in recent years, and it's estimated to affect about 16 million Americans. It's a type of a ...
Apr 24, 2017 ... (Reuters) - Large drugmakers with piles of cash are on the hunt for promising medicines being developed by small companies to treat NASH, a progressive fatty liver disease poised to become the leading cause of liver transplants by 2020.
NASH is the abbreviation of nonalcoholic steatohepatitis, which is a common, often silent, disease of the liver.